US Bancorp’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $150K | Sell |
5,295
-173
| -3% | -$4.91K | ﹤0.01% | 2207 |
|
|
2025
Q1 | $161K | Sell |
5,468
-1,100
| -17% | -$32.5K | ﹤0.01% | 2131 |
|
|
2024
Q4 | $191K | Buy |
6,568
+1,324
| +25% | +$38.5K | ﹤0.01% | 2050 |
|
|
2024
Q3 | $241K | Sell |
5,244
-53,154
| -91% | -$2.44M | ﹤0.01% | 1938 |
|
|
2024
Q2 | $2.39M | Sell |
58,398
-3,706
| -6% | -$151K | ﹤0.01% | 781 |
|
|
2024
Q1 | $1.58M | Buy |
62,104
+140
| +0.2% | +$3.57K | ﹤0.01% | 931 |
|
|
2023
Q4 | $561K | Buy |
61,964
+1,497
| +2% | +$13.5K | ﹤0.01% | 1422 |
|
|
2023
Q3 | $386K | Buy |
60,467
+1,940
| +3% | +$12.4K | ﹤0.01% | 1497 |
|
|
2023
Q2 | $649K | Buy |
58,527
+1,305
| +2% | +$14.5K | ﹤0.01% | 1248 |
|
|
2023
Q1 | $878K | Sell |
57,222
-19,560
| -25% | -$300K | ﹤0.01% | 1138 |
|
|
2022
Q4 | $1.7M | Buy |
76,782
+1,320
| +2% | +$29.3K | ﹤0.01% | 864 |
|
|
2022
Q3 | $1.23M | Sell |
75,462
-50,370
| -40% | -$822K | ﹤0.01% | 969 |
|
|
2022
Q2 | $1.83M | Buy |
125,832
+56,865
| +82% | +$826K | ﹤0.01% | 848 |
|
|
2022
Q1 | $1.27M | Sell |
68,967
-69,041
| -50% | -$1.28M | ﹤0.01% | 1073 |
|
|
2021
Q4 | $3.28M | Sell |
138,008
-118,260
| -46% | -$2.81M | 0.01% | 723 |
|
|
2021
Q3 | $6.31M | Buy |
256,268
+254,868
| +18,205% | +$6.28M | 0.01% | 515 |
|
|
2021
Q2 | $35K | Hold |
1,400
| – | – | ﹤0.01% | 2833 |
|
|
2021
Q1 | $31K | Buy |
+1,400
| New | +$31K | ﹤0.01% | 2809 |
|